Dunad

Dunad Therapeutics

Dunad Therapeutics is a biopharmaceutical company developing orally bioavailable, small-molecule protein degradation therapies for patients with oncology and central nervous system indications.

Arvinas

This biopharmaceutical company develops protein degradation therapies to treat patients with cancer and neurodegenerative diseases.

Sibylla Biotech

This company develops small molecule protein degraders for pharmaceutical partners and clinical research to treat oncological and neurodegenerative diseases.

Kesmalea Therapeutics

This drug discovery company develops oral, central nervous system penetrant protein degraders to treat oncology and neurological diseases.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.

Plexium

This company develops targeted protein degradation therapeutics and discovery platforms for patients with cancer and neurodegenerative diseases.

Cyclera Therapeutics

This company develops catalytic protein degradation therapeutics to treat neuropsychiatric, neurodegenerative and cancer disorders for patients with central nervous system diseases.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.